Parsons, H. K. and Dockrell, D. H. (2002) The burden of invasive pneumococcal disease and the potential for reduction by immunisation. International journal of antimicrobial agents, 19 (2). pp. 85-93. ISSN 0924-8579Full text not available from this repository.
Streptococcus pneumoniae causes invasive disease world-wide and in all age groups. The reported incidence varies geographically and is increased in certain population groups. The incidence is highest in children less than 2 years and is also increased in the elderly. Mortality remains substantial even in the developed world despite appropriate antimicrobial therapy. The emergence of penicillin-resistant pneumococci highlights the importance of immunisation as a means to prevent disease. This review discusses the burden of invasive pneumococcal disease, identifies high-risk patients and analyses evidence for vaccine efficacy and cost-effectiveness.
|Academic Units:||The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield)|
|Depositing User:||Miss Anthea Tucker|
|Date Deposited:||29 Mar 2012 09:44|
|Last Modified:||29 Mar 2012 09:44|
Actions (login required)